Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

71 results about "Immune infiltration" patented technology

Immune infiltration of tumours is closely associated with clinical outcome in renal cell carcinoma (RCC). Tumour-infiltrating immune cells (TIICs) regulate cancer progression and are appealing therapeutic targets.

Glioma T cell prediction and prognosis evaluation method based on pathological image

The invention discloses a glioma T cell prediction and prognosis evaluation method based on pathological images, particularly relates to the field of patient prognosis health evaluation, and aims to solve the problems that existing pathological evaluation is difficult to combine with tumor structure heterogeneity and immune infiltration distribution, and the future progress risk of a patient cannot be predicted based on follow-up visit pathological data. A spatial heterogeneity map of a tumor core area and an invasion edge is constructed in a digital pathological section, density gradients of T cells in different areas are calculated to generate a distribution heterogeneity coefficient, interaction processing is performed on the two types of characteristics in combination with historical follow-up visit records, and a time sequence neural network constructed based on a gating structure is combined to obtain a high-efficiency characteristic of the tumor. And outputting disease progress probabilities of a plurality of follow-up visit time points in the future to form a prognosis trajectory prediction curve, calculating a quantitative recurrence risk score according to curve slope change and an immune fluctuation mode, and finally generating an individualized management scheme, thereby realizing quantitative prediction evaluation and risk management of the prognosis trend of the glioma patient.
Owner:FUJIAN MEDICAL UNIV

Lung adenocarcinoma prognosis risk prediction model and construction method and application thereof

The invention discloses a lung adenocarcinoma prognosis risk prediction model and a construction method and application thereof, and belongs to the technical field of biomedical detection. The lung adenocarcinoma (LUAD) prognosis model is successfully constructed by systematically analyzing the immune infiltration related gene (CAFRG) of tumor-associated fibroblasts (CAF), and the application value of the lung adenocarcinoma (LUAD) prognosis model in prediction of patient prognosis is verified. The CAFRG risk score is negatively related to the immune microenvironment score and is remarkably related to immune checkpoint gene expression, which suggests that a high-risk patient may have the characteristic of immune escape. Furthermore, based on TIDE tool analysis, the patients in the low-risk group have more active T cell immune response. The risk score is also closely related to the sensitivity of antitumor drugs, especially Doramapimod. Therefore, a new theoretical basis is provided for personalized treatment of lung adenocarcinoma, and a new direction is provided for future clinical research.
Owner:SUZHOU UNIV

Experimental method for relation between cytokine level and tumor immune microenvironment in circulation

The invention discloses an experimental method for relation between cytokine level and tumor immune microenvironment in circulation, which comprises the following steps of: S1, collecting colorectal cancer patient data and normal data for contrast, and preferably screening a gene expression data set from a Gene Expression Omnibus (GEO) database; according to the method, a plurality of gene expression data sets from the GEO database are collected and analyzed, so that differential expression genes between colorectal cancer and normal tissues can be systematically identified, and a solid foundation is provided for subsequent research. The process not only covers batch correction, normalization and batch effect elimination of data, but also visually presents data distribution changes through principal component analysis, ensures the accuracy and reliability of analysis results, confirms that IL6 and IFN gamma are one of the most critical factors affecting the colorectal cancer immune microenvironment, and participate in formation of immune infiltration.
Owner:CHONGQING MEDICAL UNIVERSITY

Genetically engineered bacterium exosome vesicle and application thereof in preparation of medicine for treating tumors

The invention provides a genetically engineered bacterial exosome vesicle and application thereof in preparation of a medicine for treating tumors, and comprises a genetically engineered bacterial exosome vesicle Neo-MICBOMVs, and the surface of the genetically engineered bacterial exosome vesicle Neo-MICBOMVs is loaded with a fusion protein composed of a tumor neoantigen protein and an MICB [alpha] 3 structural domain protein. The fusion protein can be used as a vaccine pharmaceutical composition for treating tumors, can be used as a targeting antigen presenting cell, can promote activation of an immune system, can increase immune infiltration in a tumor microenvironment, can inhibit immune escape of tumor cells, and can improve the effect of tumor immunotherapy.
Owner:MENGCHAO HEPATOBILIARY HOSPITAL OF FUJIAN MEDICAL UNIV

Recognition method of key mitochondrial autophagy and ferroptosis genes in sepsis-induced ARDS and immunoregulation mechanism thereof

The invention discloses a method for identifying key mitochondrial autophagy and ferroptosis genes in sepsis-induced ARDS and an immunoregulation mechanism of the key mitochondrial autophagy and ferroptosis genes. The method comprises the following steps: screening differential expression genes DEGs related to the sepsis-induced ARDS from a GEO gene expression database; and screening the DEGs by using LASSO and SVM + RFE, and identifying 12 key DEGs. The diagnostic potential of the genes in sepsis-induced ARDS is verified through an ROC curve, and the effect of the genes in immune response is disclosed through gene enrichment analysis and immune infiltration analysis. According to the invention, a key gene FTH1 is identified, a miRNA gene [miR-224-5p] targeting the FTH1 and a pathologic process in which the miRNA gene [miR-224-5p] participates in regulation and control of sepsis-induced ARDS are found, and a close relationship between the FTH1 and E3 ubiquitin ligase SMURF1 is found.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIV +1

Application of GABA-A receptor negative regulator in preparation of medicine for treating panthenic cancer

The invention provides an application of a GABA-A receptor negative regulator in preparation of a medicine for treating pan cancer, and belongs to the technical field of medicines. The research finds that in the tumor microenvironment of panthenic cancer, the GABA-A receptor negative regulator acts on the key cancer-promoting gene target of cancer cells for drug therapy, abnormal overexpression of the key cancer-promoting gene causing cancer occurrence and development can be controlled, the inhibition effect of the cancer cells on immune cells is reduced, and the cancer-promoting effect of the cancer cells is improved. The medicine can be used for treating cancer cells, so that an immunosuppressive tumor microenvironment beneficial to cancer cell growth is destroyed, immune infiltration of the cancer tumor microenvironment is readjusted, a normal immune system of an organism is activated to treat the cancer cells, and the medicine can also be used for reducing NF-kb signal channels of the cancer cells to reduce inflammatory factor expression of the cancer cells and promote apoptosis of the cancer cells. The GABA-A receptor negative regulator acts on key cancer promoting gene targets of cancer cells, so that accurate and effective targeted therapy can be carried out on cancers on the molecular level.
Owner:THE AFFILIATED HOSPITAL OF GUIZHOU MEDICAL UNIV

Targeting immune infiltration to the central nervous system (CNS)

A method of treating an inflammatory disease or disorder of the central nervous system (CNS) in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of an agent capable of binding CD157 on CD157-expressing cells of the CNS, the agent capable of mediating a therapeutic effect.
Owner:RAMOT AT TEL AVIV UNIVERSITY LTD

Bionic nano preparation as well as preparation method and application thereof

The invention discloses a bionic nano preparation as well as a preparation method and application thereof. Interleukin-2 and curcumin are encapsulated by polylactic acid-glycolic acid copolymer-polyethylene glycol, then the periphery of the formed nanoparticles is coated with a manganese oxide shell, the nano-composite is coated with a cell membrane, the nano-composite has a multi-layer composite structure, the cell membrane on the outermost layer provides tumor targeting, and the nano-composite has an anti-tumor effect. After reaching a tumor microenvironment, the manganese oxide shell is quickly degraded, the process is accompanied by a tumor killing effect so as to activate anti-tumor adaptive immunity, and manganese ions in a degradation product can activate anti-tumor innate immunity and enhance immune infiltration of T cells. When manganese oxide is degraded completely, interleukin-2 and curcumin begin to be slowly released so as to promote T cell proliferation in a tumor microenvironment and inhibit expression of an immune examination site PD-L1. Therefore, the multifunctional bionic nano preparation developed by the invention provides a new choice for tumor immunotherapy, and has good clinical application and development values.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE

Pulmonary fibrosis organ-like model and construction method and application thereof

The invention relates to the technical field of organoid culture, in particular to a pulmonary fibrosis organoid model and a construction method and application thereof. The pulmonary fibrosis organ-like model is obtained by co-culturing lentivirus stably transfected alveolar epithelial cells, human embryonic lung fibroblasts MRC-5 and macrophages. According to the invention, macrophages are innovatively introduced, a ternary co-culture system of lentivirus stably transfected alveolar epithelial cells, human embryonic lung fibroblasts MRC-5 and macrophages is constructed, and a key'epithelial injury-immune infiltration-fibroblast activation 'pathological triangle in a pulmonary fibrosis pathogenesis process can be more comprehensively simulated; the finally obtained pulmonary fibrosis organ-like model provides an efficient tool for pulmonary fibrosis mechanism research and research, development and screening of anti-pulmonary fibrosis drugs.
Owner:SHANGHAI CELLIVER BIOTECHNOLOGY CO LTD +1

Co-culture microsphere model with core-shell structure and preparation method of co-culture microsphere model

The invention relates to a co-culture microsphere model with a core-shell structure and a preparation method of the co-culture microsphere model. The co-culture microsphere model comprises a core-shell microsphere, the core-shell microsphere is composed of an inner core and an outer shell, the inner core is an organoid loaded by matrigel, the outer shell is formed by crosslinking a photo-crosslinking hydrogel material, co-culture cells are doped in the photo-crosslinking hydrogel material, and the inner core is wrapped by the outer shell. According to the co-culture microsphere model, double-layer structure microspheres of co-culture cell wrapped organoids are formed, immune infiltration and in-vivo characteristics can be simulated, and a similar in-vivo three-dimensional tumor immune microenvironment is provided. And the types of cells loaded on the inner layer and the outer layer can be flexibly replaced to form a microsphere model for co-culture of single or multiple cells and organoids. The co-culture microsphere model is more stable in structure, the size of the diameter of the core-shell microsphere can be optimized by changing 3D printing parameters, the operability of subsequent research is high, and the co-culture microsphere model is suitable for different research application scenes.
Owner:QINGYUAN ZHIXIN (SHENZHEN) BIOTECHNOLOGY CO LTD

Application of combination of FXR agonist and PD1 / PD-L1 monoclonal antibody in preparation of anti-hepatoma drugs

The invention belongs to the technical field of biological medicines, and particularly relates to application of an FXR agonist combined with a PD1 / PD-L1 monoclonal antibody in preparation of an anti-liver cancer medicine, in particular to application of obeticholic acid (OCA) combined with a Czodiasumab in treatment of liver cancer. The invention also provides an application of the nuclear receptors FXR and PD1 in liver cancer treatment, specifically, the nuclear receptors FXR and PD1 are taken as double targets, and the medicine for treating liver cancer is obtained. An FXR agonist OCA is used for activating FXR, and it is found that activation of FXR can regulate immune infiltration of T cells by promoting polarization of macrophage M1, so that growth of tumors is inhibited. In addition, expression of PD-L1 in liver cancer can be promoted by activating FXR, and a better tumor inhibition effect can be achieved by combining an FXR agonist OCA with a PD1 monoclonal antibody for immunotherapy.
Owner:INNER MONGOLIA MEDICAL UNIV

New uses of jak inhibitors and medicaments to promote skin stretch regeneration

The application discloses a new application of a JAK inhibitor and a medicine for promoting skin stretch regeneration, and application of the JAK inhibitor in preparation of the medicine for promoting skin stretch regeneration; the medicine for promoting skin stretch regeneration comprises the following components: a JAK inhibitor and a carrier, wherein the carrier comprises sodium hyaluronate and propylene glycol; the application provides a new application of the JAK inhibitor, and the JAK inhibitor can promote skin stretch regeneration, in particular, can promote increase of hair follicle density, increase of epidermis thickness, increase of dermis thickness, reduction of fibrosis degree, reduction of immune infiltration degree and reduction of myofibroblast quantity after skin expansion.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1

Immune infiltrated desert tumor benefit ici treatment method based on weighted strategy

The present application relates to the field of biomedical technology, and discloses an immune infiltration desert tumor benefit ICI treatment method based on a weighting strategy. The method obtains spatial transcriptome data of tumor tissue of a patient, divides the tumor microenvironment into functional regions through an adaptive grid division algorithm, and extracts a multi-scale feature vector; calculates dynamic weight coefficients of each functional region using a graph attention network, and generates a comprehensive response index after weighted integration; and finally outputs an individualized ICI treatment decision according to the comparison result of the index and a preset threshold. The present application realizes dynamic evaluation of tumor microenvironment heterogeneity based on spatial transcriptome data, and provides ICI treatment response prediction and clinical decision support for patients with immune infiltration desert tumors.
Owner:吴玥

Lung adenocarcinoma prognosis and immune infiltration related prediction model and construction method and application thereof

The invention discloses a lung adenocarcinoma prognosis and immune infiltration related prediction model. By deeply mining data in TCGA and GEO databases, a prognosis model based on eight pyroptosis related genes is constructed, and compared with a traditional method, the five-year survival prognosis of a lung adenocarcinoma patient can be more accurately predicted. A verification result shows that the model has relatively high accuracy (AUC = 0.687) in prediction of the total survival of one year, and through Kaplan-Meier analysis and Log-Rank inspection, survival differences of patients in high and low risk groups in a training set and a verification set are remarkably distinguished. The research method and the model have strong universality, provide important reference for research and application of a pyroptosis related mechanism in other cancer types, promote the progress of the oncology field in the research related to the pyroptosis mechanism, and have wide clinical application value.
Owner:DONGGUAN PEOPLES HOSPITAL

Application of cobalt complex in preparation of medicine for treating pancreatic cancer

The invention discloses application of a cobalt complex in preparation of a medicine for treating pancreatic cancer. According to the invention, a series of small molecule compounds are artificially synthesized through a machine learning algorithm assisted drug design, and the pancreatic cancer resisting effect of the small molecule compounds is evaluated in an animal model. The cobalt complex Co68 can effectively induce macrophages in a tumor microenvironment to secrete type I interferon, so that the tumor microenvironment of pancreatic cancer is remodeled. In addition, the Co68 remarkably increases immune infiltration of natural killer cells, killer CD8 + T cells and the like in the pancreatic cancer tumor microenvironment, and further enhances the anti-tumor effect. Therefore, the cobalt complex Co68 has a wide application prospect in the field of treatment of cold tumors such as pancreatic cancer.
Owner:PEKING UNIV +1

A genetic locus marker of immune infiltration function associated with colorectal cancer susceptibility and prognosis and its application

The present invention relates to an immune infiltration function genetic locus associated with susceptibility and prognosis of colorectal cancer and its application, wherein the marker is rs1360948. The rs1360948 locus has the most significant colorectal cancer immunQTL effect value, and individuals carrying the rs1360948 [G] genotype are more likely to bind to the transcription factor PRDM1, thereby causing the target gene CCL2 to express more, promoting cancer cell proliferation, leading to an increased risk of individual colorectal cancer and a poor prognosis for colorectal cancer patients. By cleverly designing primers and probes for the rs1360948 locus, the rs1360948 risk locus can be detected in normal people or colorectal cancer patients by fluorescent quantitative PCR, and the high-risk population for colorectal cancer can be identified, the prognosis of colorectal cancer patients can be predicted, and the high-risk population for colorectal cancer and the population with the possibility of poor prognosis of colorectal cancer patients can be screened as an auxiliary method.
Owner:WUHAN UNIV

Cerebral arterial thrombosis diagnosis model based on neutrophil extracellular trap genes

The invention relates to a cerebral arterial thrombosis diagnosis model based on neutrophil extracellular trap genes, and belongs to the field of clinical medicine. The method is high in sensitivity and good in diagnosis effect, complex gene expression data is converted into a visual scoring tool, and the clinical applicability is improved; gene expression, immune infiltration and single cell sequencing data are integrated through multi-omics data fusion, an IS pathological mechanism is comprehensively analyzed, a high-specificity gene combination is screened through a Boruta algorithm and CytoHubba, traditional single-gene limitation is broken through, meanwhile, it is revealed for the first time that NETs influences IS progress by regulating neutrophil infiltration, a new target is provided for immunotherapy, and the method has the advantages of being high in specificity and good in immunotherapy effect. Compared with the prior art, the method is obviously improved.
Owner:THE AFFILIATED HOSPITAL OF XUZHOU MEDICAL UNIV

Osteoporosis collagen related biomarker and application thereof

According to the osteoporosis collagen related biomarker and the application thereof, the collagen related biomarkers RANBP1 and SOCS3 are found in OP through multi-omics analysis, an ROC curve model with excellent performance is constructed based on the two biomarkers, and the onset risk of OP can be effectively predicted; the invention relates to an OP diagnosis marker, in particular to an application of RANBP1 and SOCS3 in bone metabolism, which covers function enrichment analysis, immune infiltration evaluation, regulation network construction, drug prediction and molecular docking analysis, reveals the potential of RANBP1 and SOCS3 as OP diagnosis markers, clarifies the effect of RANBP1 and SOCS3 in bone metabolism through a JAK-STAT pathway and an immune regulation network, and provides molecular and clinical basis for early diagnosis and targeted therapy of OP.
Owner:JIANGXI PROVINCIAL PEOPLES HOSPITAL

Method for analyzing and identifying autophagy biomarkers related to atherosclerotic plaque progress

The invention provides a method for analyzing and identifying an autophagy biomarker related to atherosclerotic plaque progress, and belongs to the technical field of analysis. Comprising the following steps: (1) data acquisition and processing; (2) identifying differentially expressed genes and autophagy related genes; (3) key gene verification and prediction efficiency evaluation; (4) immune infiltration analysis; (5) single cell RNA sequencing analysis; and (6) expression of the three genes in macrophages. According to the invention, autophagy related genes related to AS are identified, and the expression mode, spatial distribution and immune infiltration characteristics of key differential expression genes are clarified by adopting a multi-omics method. The research result of the invention provides a new insight and potential intervention treatment target for understanding the molecular mechanism of AS.
Owner:KUNMING MEDICAL UNIVERSITY +1

Application of nintedanib in preparation of medicine for treating migration plant mineralization

The invention discloses application of nintedanib in preparation of a medicine for treating plant migration and plant mineralization, and belongs to the technical field of biological medicine. The research shows that the nintedanib has the effects of reducing deposition of extracellular matrix of an allogeneic kidney transplantation model mouse, improving renal tubular atrophy, relieving mouse CD206 + macrophage infiltration and reducing rejection injury degree and immune infiltration degree of kidney grafts after being administered under the administration dosage without generating liver and kidney toxicity and intestinal side effects; the lesion process of mouse chronic transplanted kidney rejection is obviously slowed down, and the damage of excessively activated inflammatory cells to the transplanted kidney is reduced. The results show that nintedanib can delay the progress of chronic transplantation renal fibrosis.
Owner:THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIV

A multi-modal approach to predicting immune infiltration based on integrated RNA expression and imaging features

Multi-modal approaches to predict tumor immune infiltration are based on integrating gene expression data and imaging features in a neural network-based framework. This framework is configured to estimate percent composition, and thus immune infiltration score, of a patient tumor biopsy sample. Multi-modal approaches may also be used to predict cell composition beyond immune cells via integrated multi-layer neural network frameworks.
Owner:TEMPUS AI INC

CAR-T cell based on secretion enhancement strategy as well as preparation method and medical application of CAR-T cell

The invention discloses a CAR-T cell based on a secretion enhancement strategy as well as a preparation method and medical application thereof. The constructed asCAR-T cell contains a secretion-enhanced chimeric antigen receptor (asCAR for short) and small interfering nucleic acid of DDR1 protein. The asCAR sequentially comprises a single-chain variable fragment scFv, a hinge region, a transmembrane domain, a costimulatory factor, a signal transduction structural domain CD3 zeta and TNFRSF1B ICD from an extracellular structure to an intracellular structure, wherein the TNFRSF1B ICD is a TRAF2 binding structural domain in a TNFR2 cell; the small interfering nucleic acid of the DDR1 protein comprises shRNA-DDR1 (short hairpin ribonucleic acid) or miRNA-DDR1 (micro ribonucleic acid). After the antigen activates the asCAR-T cells, the ICD of the TNFRSF1B enhances the expression of the PD-1 through the NF-kappa B pathway and releases the extracellular vesicles loaded with the shRNA-DDR1 or the miRNA-DDR1. The extracellular vesicles released by the asCAR-T cells degrade PD-L1 on the surfaces of tumor cells and inhibit DDR1 expression, and the immune infiltration and anti-tumor effects of the asCAR-T cells are enhanced based on the positive feedback loop.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration

Aspects of the disclosure relate to methods, systems, and computer-readable storage media that are useful for characterizing subjects having certain cancers, for example cancers typified by solid tumors. The disclosure is based, in part, on methods for determining a tumor microenvironment (TME) type of a cancer subject and determining the subject's prognosis and / or likelihood of responding to one or more therapies based upon the TME type determination.
Owner:BOSTONGENE CORP

Bioinformatics analysis method for identifying gene target points related to prognosis of cerebral hemorrhage

The application discloses a bioinformatics analysis method for identifying a brain hemorrhage prognosis-related gene target point, and the method comprises the following steps: obtaining brain hemorrhage transcriptome expression data, performing quality filtering and batch correction to generate a standardized expression matrix, performing differential expression analysis on the basis of the standardized expression matrix, screening prognosis-associated differential genes in combination with survival regression, constructing a weighted co-expression network to identify a prognosis key gene cluster, screening and verifying a core hub gene through hub degree, taking the intersection of the prognosis-associated differential genes and the core hub gene, filtering and interaction network clustering a core target gene through a pathological pathway, performing immune infiltration correlation analysis and survival analysis on the basis of the core target gene, and outputting the brain hemorrhage prognosis-related gene target point according to an immune correlation marker and a survival correlation index. The application integrates a differential analysis and a network analysis double strategy, confirms mechanism correlation through pathway verification and immune correlation analysis, and the screening result has statistical reliability and biological interpretability.
Owner:THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV

Colorectal cancer multi-target prognosis risk assessment model construction method based on palmitoylation-related lncRNA

The invention discloses a colorectal cancer multi-target prognosis risk assessment model construction method based on palmitoylation related lncRNA, and relates to the technical field of colorectal cancer prognosis model construction. The method comprises the following steps: step 1, data acquisition; step 2, identifying lncRNA (long non-coding ribonucleic acid) related to S-palmitoylation; step 3, determining a key lncRNA (long non-coding RNA) for constructing a prognosis model; 4, establishing a risk scoring model; and 5, testing the prognosis model. Based on a TCGA database, palmitoylation related genes and CRC transcriptome data are integrated, lncRNA significantly related to the palmitoylation related genes and the CRC transcriptome data is screened through co-expression analysis, and a multi-target prognosis risk assessment model based on the palmitoylation related lncRNA is constructed. And further model testing and mechanism exploration, immune infiltration and mutation load evaluation, drug sensitivity prediction and the like are carried out, so that a more accurate prognosis evaluation tool is expected to be provided for CRC patients, the development of mechanism-driven individualized treatment strategies is promoted, and the method has important significance in improving treatment of the patients and increasing the survival rate.
Owner:NANCHANG UNIV

Application of RBSN detection reagent in preparation of colorectal cancer detection / prognosis prediction product

PendingCN119224308Aprolong lifeBiological testingFocal adhesionECM-receptor interaction
The invention discloses application of an RBSN detection reagent in preparation of a colorectal cancer detection / prognosis prediction product, and belongs to the technical field of colorectal cancer diagnosis markers. It is found through information generation analysis that compared with normal tissue, the expression level of RBSN in colorectal cancer tumor tissue is lower, and patients with high expression of RBSN have longer lifetime than patients with low expression of RBSN. RBSN expression differential genes are obviously enriched on related paths such as digestion and absorption of protein, ECM receptor interaction, proteoglycan in diabetic cardiomyopathy, oxidative phosphorylation, adherence, cancer, thermogenesis, chemical carcinogenesis of active oxygen and the like, and are positively correlated with immune infiltration. Immunohistochemical experiments prove that the coding protein Rabinosyn-5 of the RBSN is expressed in tumor tissues and para-carcinoma normal tissues of the colorectal cancer and is mainly expressed in cytoplasm, the expression of the RBSN is obviously related to the prognosis of the colorectal cancer patient, and the prognosis lifetime of the colorectal cancer patient with high expression of the RBSN is longer.
Owner:THE PEOPLES HOSPITAL SHAANXI PROV

A detection kit for B cells and high endothelial venules in the immune microenvironment of thymus tissue

ActiveCN119290545BPreparing sample for investigationDisease diagnosisAutoimmune responsesCD31
The present invention relates to a detection kit for B cells and high endothelial venules in the immune microenvironment of thymus tissue, comprising quantum dot-labeled antibody CD19, quantum dot-labeled antibody CD1d, quantum dot-labeled CD31 and quantum dot-labeled PNad. After the specific antibody coupled with the quantum dot is specifically combined with the antigen on the B cell and high endothelial venule on the tissue section sample, the quantum dot can be used to quantify or locate the B cell and high endothelial venule. Instead of the traditional multicolor immunofluorescence technology, the method of directly carrying specific antibodies with quantum dots is used to save experimental time and improve work efficiency. The expression of B cells and Breg cells in the thymus immune microenvironment and the expression of high endothelial venules can be detected, and at the same time, the relative spatial positions of the above cells and blood vessels can be observed, which directly reflects the state of immune infiltration and autoimmune reaction in the thymus immune microenvironment, and has broad application prospects in the thymus-related immunity and tumor fields.
Owner:TIANJIN MEDICAL UNIV GENERAL HOSPITAL AIRPORT HOSPITAL

Application of ICAT gene as treatment target in cervical cancer

The invention discloses application of an ICAT gene as a treatment target in cervical cancer, and relates to the technical field of biomedicine and oncology. The prognosis of the patient is evaluated by detecting the expression level of ICAT in cervical cancer tissues; the detection method comprises the following steps: S1, analyzing correlation between ICAT and CC immune infiltration by a clinical sample; s2, identifying that ICAT promotes the malignant progression of cervical cancer through glycolysis; s3, determining a molecular mechanism for regulating and controlling ENO1 expression by ICAT to remodel cervical cancer glycolysis reprogramming; s4, determining a molecular mechanism of ICAT-dependent lactic acid accumulation for triggering polarization of tumor-associated macrophages; and S5, evaluating a result. According to the invention, ICAT remodeling cervical cancer metabolism reprogramming is taken as an entry point, and ICAT is revealed from the aspects of cells, animals and tissues to promote the activity of cervical cancer tumors, and has clinical value.
Owner:CHONGQING MEDICAL UNIVERSITY

Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration

Aspects of the disclosure relate to methods, systems, and computer-readable storage media that are useful for characterizing subjects having certain cancers, for example cancers typified by solid tumors. The disclosure is based, in part, on methods for determining a tumor microenvironment (TME) type of a cancer subject and determining the subject's prognosis and / or likelihood of responding to one or more therapies based upon the TME type determination.
Owner:BOSTONGENE CORP

Bioinformatics analysis method for identifying cerebral hemorrhage prognosis related gene target

The invention relates to a bioinformatics analysis method for identifying cerebral hemorrhage prognosis related gene targets. The method comprises the following steps: acquiring cerebral hemorrhage transcriptome expression data and implementing quality filtering and batch correction to generate a standardized expression matrix; performing differential expression analysis according to the standardized expression matrix, and screening prognosis associated differential genes in combination with survival regression; constructing a weighted co-expression network to identify a prognosis key gene cluster, and obtaining a core hub gene through hub degree screening and cross-dataset verification; after intersection of the prognosis associated differential genes and the core hub genes is obtained, core target genes are recognized through pathological pathway filtering and interaction network clustering; and carrying out immune infiltration correlation analysis and survival analysis based on the core target gene, and outputting cerebral hemorrhage prognosis related gene targets according to immune correlation markers and survival correlation indexes. According to the method, dual strategies of difference analysis and network analysis are integrated, mechanism relevance is confirmed through pathway verification and immune relevance analysis, and a screening result has statistical reliability and biological interpretability.
Owner:THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV